United States securities and exchange commission logo





                              May 15, 2023

       Kimball Carr
       Chief Executive Officer
       Inspire Veterinary Partners, Inc.
       780 Lynnhaven Parkway
       Suite 400
       Virginia Beach, VA 23452

                                                        Re: Inspire Veterinary
Partners, Inc.
                                                            Amendment No. 1 to
Registration Statement on Form S-1
                                                            Filed April 25,
2023
                                                            File No. 333-271198

       Dear Kimball Carr:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our April
14, 2023 letter.

       Amendment No. 1 to Form S-1 filed April 25, 2023

       Anticipated Growth through Acquisitions, page 4

   1.                                                   We note your revisions
in response to our prior comment 1, including your statement that
                                                        approximately $8.2
million of your outstanding indebtedness is convertible into shares of
                                                        Class A common stock.
Please further revise to clarify if that entire amount is reflected in
                                                        the 2,648,656 shares
reflected in the table on page 9, and whether the entire amount of that
                                                        indebtedness is
automatically or mandatorily convertible in connection with the primary
                                                        offering, or otherwise
expected to be converted in connection with the primary offering.
 Kimball Carr
FirstName  LastNameKimball     Carr
Inspire Veterinary Partners, Inc.
Comapany
May        NameInspire Veterinary Partners, Inc.
     15, 2023
May 15,
Page  2 2023 Page 2
FirstName LastName

The Offering, page 8

2.       We note your revisions in response to our prior comment 2 and reissue
in part. There are
         still several discrepancies in your prospectus. For example, the
shares of class A common
         stock that are potentially issuable upon conversion of Class B common
stock held by non-
         affiliates do not appear to be included in the total shares of Cass A
common stock being
         offered in this filing that are set forth in the table on page 9,
despite the lead-in narrative
         and the amounts disclosed elsewhere, such as in footnote 8 to the
selling stockholder
         table. Please also revise to address other discrepancies, such as the
number of shares of
         Class A common stock that are issued and outstanding, as we note three
different amounts
         stated throughout your prospectus as of the date of the prospectus,
and the number of
         shares of Class A common stock issuable upon exercise of your
warrants.
The sale or availability for sale of substantial amounts of our Class A common
stock could
adversely affect their market price, page 24

3.       We acknowledge your revised disclosures in response to comment 4. As
previously noted,
         please also revise your risk factor to describe the risk to purchasers
in your primary
         offering that the large number of shares being offered in the resale
transaction could
         depress the market price of your common stock. In addition, we note
your revised
         disclosure on page 30, which indicates that you are not registering
the Class A common
         stock to be held by Messers. Carr, Coleman, Keiser, Lau and Marten,
upon conversion of
         their shares of Class B common stock. However, you continue to appear
to state on page
         24 that those shares are being registered by this prospectus. Please
revise your disclosure
         to address this discrepancy, and ensure that footnotes to the selling
stockholder table are
         appropriately updated, including footnote 5.
Liquidity and Capital Resources, page 42

4.       As previously requested, please disclose on page 42 whether you are
currently in
         compliance with all of your debt covenants and also whether there have
been any
         instances of non-compliance during the periods presented and through
the date of this
         filing.
Security Ownership of Certain Beneficial Owners and Management, page 69

5.       Please revise your selling stockholder table and beneficial ownership
table to reflect
         information as of a recent date. Please also revise to explain the
exclusion of shares noted
         in footnotes 3 and 8. Refer to Item 403 of Regulation S-K. In
addition, we note your
         disclosure in a prior amendment that Star Circle Advisory had
distributed 333,250 shares
         of Class B common stock to Mr. Carr. However, we note your revised
disclosure on page
         71 that Star Circle initially purchased 2,150,000 shares of Class B
common stock. Please
         revise the beneficial ownership table to reflect similar distributions
to other individuals or
         Star Circle's remaining ownership, or advise.
 Kimball Carr
Inspire Veterinary Partners, Inc.
May 15, 2023
Page 3
Exhibits

6.     We note that you have filed additional exhibits. Please revise your
exhibit index to ensure
       that it properly reflects your filed exhibits.
       You may contact Nudrat Salik at 202-551-3692 or Al Pavot at 202-551-3738
if you have
questions regarding comments on the financial statements and related matters.
Please contact
Jordan Nimitz at 202-551-5831 or Dorrie Yale at 202-551-8776 with any other
questions.



                                                            Sincerely,

FirstName LastNameKimball Carr                              Division of
Corporation Finance
                                                            Office of
Industrial Applications and
Comapany NameInspire Veterinary Partners, Inc.
                                                            Services
May 15, 2023 Page 3
cc:       Joe Laxague, Esq.
FirstName LastName